New Screening Process May Speed Work on SMN2 Splicing Approaches to Treat SMA, Study Says
A research team in Korea created an in vitro, or laboratory, model to screen and validate medicines that aim to treat spinal muscular atrophy (SMA) by promoting protein production by the SMN2 gene. The system is based on the use of a special cell line as well as stem cells…